Stem is trading 6.6% down at $3.10 amid a broad risk-off session, with major indexes lower and technology shares under pressure. - Technology weakness comes amid concerns about AI spending and renewed Middle East tensions. - No fresh Stem-specific announcement explaining the October 22 decline surfaced in the search. - BMO cut its price target to $5 from $8 on October 21; available reporting does not establish it as the direct cause of today’s move.